AI-accelerated therapeutic antibody development: practical insights
Antibodies represent the largest class of biotherapeutics thanks to their high target specificity, binding affinity and versatility. Recent breakthroughs in Artificial Intelligence (AI) have enabled information-rich in silico representations of antibodies, accurate prediction of antibody structure f...
Saved in:
Main Authors: | Luca Santuari (Author), Marianne Bachmann Salvy (Author), Ioannis Xenarios (Author), Bulak Arpat (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seq2scFv: a toolkit for the comprehensive analysis of display libraries from long-read sequencing platforms
by: Marianne Bachmann Salvy, et al.
Published: (2024) -
An accelerated surface-mediated stress assay of antibody instability for developability studies
by: Marie R.G. Kopp, et al.
Published: (2020) -
University Students' Attitudes toward Artificial Intelligence: An Exploratory Study of the Cognitive, Emotional, and Behavioural Dimensions of AI Attitudes
by: Argyrios Katsantonis, et al.
Published: (2024) -
Accelerating pharmaceutical R&D with a user-friendly AI system for histopathology image analysis
by: Brendon Lutnick, et al.
Published: (2023) -
Applying artificial intelligence to accelerate and de-risk antibody discovery
by: Astrid Musnier, et al.
Published: (2024)